Iovance Biotherapeutics
$24.009876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$24.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.27 (+1.13%) Today
-$0.10 (-0.41%) As of 6:44 PM EST after-hours
Why Robinhood?
You can buy or sell IOVA and other stocks, options, ETFs, and crypto commission-free!
About IOVA
Iovance Biotherapeutics, Inc. operates as a biotechnology company, which engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. Read More The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.
CEO
Employees
88
Headquarters
San Carlos, California
Founded
2007
Market Cap
3.01B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
823.59K
High Today
$24.24
Low Today
$23.59
Open Price
$23.82
Volume
922.27K
52 Week High
$29.68
52 Week Low
$9.21
Collections
Analyst Ratings
100%
of 10 ratings
Buy
100%
Hold
0%
Sell
0%
IOVA Earnings
-$0.40
-$0.27
-$0.13
$0.00
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
— per share
Actual
Expected Feb 27, After Hours
People Also Bought
Viking Therapeutics
38,274
$6.65
-1.19%Cara Therapeutics
24,563
$17.19
-3.35%Hexo
166,738
$1.47
-3.29%Amarin
16,082
$18.25
+3.58%Corbus Pharmaceuticals
49,160
$5.68
+3.18%Catalyst Pharmaceuticals
48,940
$5.25
+10.06%TG Therapeutics
5,270
$15.86
+0.51%Verastem
17,386
$2.03
+1.50%Vivint Solar
65,723
$11.02
+1.01%CRISPR
26,685
$55.75
-0.09%Aurora Cannabis
660,838
$1.66
+5.06%Plug Power
190,620